Background: Women with gestational diabetes (GDM) have an increased risk of metabolic syndrome (MS) after delivery. MS could precede gravidity. The aims of this study were (i) to detect the prevalence of MS in women at the time of GDM diagnosis, (ii) to detect the prevalence of MS in the subgroup of GDM patients with any form of impaired glucose tolerance after delivery (PGI), and (iii) to determine whether GDM women with MS have a higher risk of peripartal adverse outcomes. Methods: A cross-sectional observational study comprised n = 455 women with GDM. International Diabetes Federation (IDF) criteria for MS definition were modified to the pregnancy situation. Results: MS was detected in 22.6% of GDM patients in those with PGI 40%. The presence of MS in GDM patients was associated with two peripartal outcomes: higher incidence of pathologic Apgar score and macrosomia (p = 0.01 resp. p = 0.0004, chi-square). Conclusions: The presence of MS in GDM patients is a statistically significant risk factor (p = 0.04 chi-square) for PGI. A strong clinical implication of our findings might be to include MS diagnostics within GDM screening using modified MS criteria in the second trimester of pregnancy.

Department of Obstetrics and Gynaecology University Hospital Brno 66263 Brno Czech Republic

Department of Pathophysiology Faculty of Medicine Masaryk University 62500 Brno Czech Republic

Zobrazit více v PubMed

Zhang X., Gregg E.W., Williamson D.F., Barker L.E., Thomas W., Bullard K.M., Imperatore G., Williams D.E., Albright A.L. A1C level and future risk of diabetes: A systematic review. Diabetes Care. 2010;33:1665–1673. doi: 10.2337/dc09-1939. PubMed DOI PMC

American Diabetes Association Professional Practice Committee 2 Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022. Diabetes Care. 2021;45((Suppl. S1)):S17–S38. doi: 10.2337/dc22-s002. PubMed DOI

Keely E. An opportunity not to be missed—How do we improve postpartum screening rates for women with gestational diabetes? Diabetes/Metab. Res. Rev. 2012;28:312–316. doi: 10.1002/dmrr.2274. PubMed DOI

Bellamy L., Casas J.P., Hingorani A.D., Williams D. Type 2 diabetes mellitus after gestational diabetes: A systematic review and meta-analysis. Lancet. 2009;373:1773–1779. doi: 10.1016/S0140-6736(09)60731-5. PubMed DOI

Di Cianni G., Miccoli R., Volpe L., Lencioni C., Del Prato S. Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes/Metab. Res. Rev. 2003;19:259–270. doi: 10.1002/dmrr.390. PubMed DOI

Szmuilowicz E.D., Josefson J.L., Metzger B.E. Gestational Diabetes Mellitus. Endocrinol. Metab. Clin. N. Am. 2019;48:479–493. doi: 10.1016/j.ecl.2019.05.001. PubMed DOI PMC

Pathirana M.M., Lassi Z.S., Ali A., Arstall M.A., Roberts C.T., Andraweera P.H. Association between metabolic syndrome and gestational diabetes mellitus in women and their children: A systematic review and meta-analysis. Endocrine. 2021;71:310–320. doi: 10.1007/s12020-020-02492-1. PubMed DOI

World Health Organization . Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. World Health Organization; Geneva, Switzerland: 2013.

Alberti K.G., Zimmet P., Shaw J. Metabolic syndrome—A new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet. Med. 2006;23:469–480. doi: 10.1111/j.1464-5491.2006.01858.x. PubMed DOI

Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 1998;15:539–553. doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S. PubMed DOI

Torgersen K.L., Curran C.A. A systematic approach to the physiologic adaptations of pregnancy. Crit. Care Nurs. Q. 2006;29:2–19. doi: 10.1097/00002727-200601000-00002. PubMed DOI

Macdonald-Wallis C., Lawlor D.A., Fraser A., May M., Nelson S.M., Tilling K. Blood pressure change in normotensive, gestational hypertensive, preeclamptic, and essential hypertensive pregnancies. Hypertension. 2012;59:1241–1248. doi: 10.1161/HYPERTENSIONAHA.111.187039. PubMed DOI PMC

Oostvogels A.J.J.M., Busschers W.B., Spierings E.J.M., Roseboom T.J., Gademan M.G.J., Vrijkotte T.G.M. Pre-pregnancy weight status, early pregnancy lipid profile and blood pressure course during pregnancy: The ABCD study. PLoS ONE. 2017;12:e0177554. doi: 10.1371/journal.pone.0177554. PubMed DOI PMC

Ryckman K.K., Spracklen C.N., Smith C.J., Robinson J.G., Saftlas A.F. Maternal lipid levels during pregnancy and gestational diabetes: A systematic review and meta-analysis. BJOG Int. J. Obstet. Gynaecol. 2015;122:643–651. doi: 10.1111/1471-0528.13261. PubMed DOI

De Long E.R., De Long D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics. 1988;44:837–845. doi: 10.2307/2531595. PubMed DOI

Youden W.J. Index for rating diagnostic tests. Cancer. 1950;3:32–35. doi: 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3. PubMed DOI

Urbanová J., Brunerová L., Nunes M.A., Brož J. MODY diabetes and screening of gestational diabetes. Ceská Gynekol. 2020;85:124–130. PubMed

Chen L.-W., E Soh S., Tint M.-T., Loy S.L., Yap F., Tan K.H., Lee Y.S., Shek L.P.-C., Godfrey K.M., Gluckman P.D., et al. Combined analysis of gestational diabetes and maternal weight status from pre-pregnancy through post-delivery in future development of type 2 diabetes. Sci. Rep. 2021;11:5021. doi: 10.1038/s41598-021-82789-x. PubMed DOI PMC

Wang C., Zhu W., Wei Y., Su R., Feng H., Hadar E., Hod M., Yang H. The associations between early pregnancy lipid profiles and pregnancy outcomes. J. Perinatol. 2017;37:127–133. doi: 10.1038/jp.2016.191. PubMed DOI

Cibickova L., Schovanek J., Karasek D. Changes in serum lipid levels during pregnancy in women with gestational diabetes. A narrative review. Biomed. Pap. Med. Fac. Palacky Univ. Olomouc. 2021;165:8–12. doi: 10.5507/bp.2021.009. PubMed DOI

Zhu S.M., Zhang H.Q., Li C., Zhang C., Yu J.L., Wu Y.T., Huang H.F. Maternal lipid profile during early pregnancy and birth weight: A retrospective study. Front. Endocrinol. 2022;13:951871. doi: 10.3389/fendo.2022.951871. PubMed DOI PMC

Grieger J.A., Bianco-Miotto T., Grzeskowiak L.E., Leemaqz S.Y., Poston L., McCowan L.M., Kenny L.C., Myers J.E., Walker J.J., Dekker G.A., et al. Metabolic syndrome in pregnancy and risk for adverse pregnancy outcomes: A prospective cohort of nulliparous women. PLoS Med. 2018;15:e1002710. doi: 10.1371/journal.pmed.1002710. PubMed DOI PMC

Wani K., Sabico S., Alnaami A.M., Al-Musharaf S., Fouda M.A., Turkestani I.Z., Al-Ajlan A., Alshingetti N.M., Alokail M.S., Al-Daghri N.M. Early-Pregnancy Metabolic Syndrome and Subsequent Incidence in Gestational Diabetes Mellitus in Arab Women. Front. Endocrinol. 2020;11:98. doi: 10.3389/fendo.2020.00098. PubMed DOI PMC

Migda M., Migda M.S., Migda B., Krzyżanowska P., Wender-Ożegowska E. Components of metabolic syndrome in the first trimester of pregnancy as predictors of adverse perinatal outcome. Ginekol. Polska. 2016;87:644–650. doi: 10.5603/GP.2016.0060. PubMed DOI

Tranidou A., Dagklis T., Tsakiridis I., Siargkas A., Apostolopoulou A., Mamopoulos A., Goulis D.G., Chourdakis M. Risk of developing metabolic syndrome after gestational diabetes mellitus—A systematic review and meta-analysis. J. Endocrinol. Investig. 2021;44:1139–1149. doi: 10.1007/s40618-020-01464-6. PubMed DOI

Some Levels of Plasma Free Fatty Acids and Amino Acids in the Second Trimester Are Linked to Gestational Diabetes and Are Predictive of Persisting Impaired Glucose Tolerance After Delivery